Publication | Closed Access

Medical costs incurred by organ damage caused by active disease, comorbidities and side effect of treatments in systemic lupus erythematosus patients: a Taiwan nationwide population-based study

Health EconomicsSystemic Lupus Erythematosus TreatmentLupusGlobal HealthMedical CostsLupus NephritisOutcomes ResearchHealth Care CostOrgan DamageActive DiseaseCost EffectivenessEconomic EvaluationMedicineHealthcare Value